Search

everythinglearnresearchcommunity

for

Search:↓

High and low doses of prednisolone helped 62% of children with severe alopecia regrow hair with some weight gain and mild acne as side effects.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

Patchy alopecia areata can affect only pigmented hairs, leaving gray hairs untouched.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

People with alopecia areata may be more likely to have a certain type of hearing loss.

Greying hairs may be protected from alopecia areata.

Blocking interferon-gamma might help treat various autoimmune diseases.

Frontal Fibrosing Alopecia might be an autoimmune disease.

Obese mice with a leptin gene mutation have a longer resting phase in their hair cycle, which may help understand certain hair loss conditions.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Alopecia areata causes hair loss with varied treatment responses and frequent relapses.

Severe alopecia areata greatly impacts quality of life, mental health, and daily activities.

Hair color is influenced by genetics and can indicate certain health conditions.

The meeting presented findings on effective treatments for various pet skin conditions and insights into the immune responses of dogs with atopic dermatitis.

Alopecia areata, a type of hair loss, may be passed through T cells and has genetic links, while treatments vary in effectiveness. Male pattern baldness can be treated with finasteride and is influenced by androgens in hair follicles.

Stress hormones and autoimmune reactions can cause hair loss.

Melanocytes might be targeted by the immune system in people with alopecia areata, but more research is needed.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

Hepatitis B virus exposure may be linked to increased risk of alopecia areata.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

Volatile organic compounds can cause inflammation and increase the risk of autoimmune diseases.

The document concludes that understanding and treatments for alopecia areata have significantly advanced, now recognizing it as an autoimmune disorder.

Topical immunotherapy is the best treatment for severe alopecia areata.

Type 1 diabetes often occurs with other autoimmune diseases, and personalized treatment based on genetics can improve outcomes.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Mesenchymal stem cells show promise for treating various skin conditions and may help regenerate hair.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Choosing the right method to separate skin layers is key for good skin cell research.